Literature DB >> 3970566

Rectal aminophylline in the management of apnoea of prematurity.

A J Lyon, N McIntosh.   

Abstract

Rectal suppositories as an alternative to intravenous aminophylline in the management of recurrent apnoea were studied in 41 preterm infants of mean gestation 28.3 weeks and mean birthweight 1176 g. Therapeutic blood concentrations were obtained two hours after a rectal loading dose of 10 mg/kg, with steady concentrations and maximum reduction in apnoeic episodes (from a mean of 0.5 per hour to 0.09 per hour) within 24 hours on a maintenance dose of 10 mg/kg/day. There was good correlation between the rectal dose and the plasma theophylline concentration. Several infants showed a significant reduction in Pco2 when treated with aminophylline. Side effects were related to the plasma theophylline concentration and were not seen at concentrations less than 14 mg/l.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3970566      PMCID: PMC1777079          DOI: 10.1136/adc.60.1.38

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  8 in total

1.  Severe toxic effects from aminophylline and theophylline suppositories in children.

Authors:  A C NOLKE
Journal:  J Am Med Assoc       Date:  1956-06-23

2.  Aminophylline poisoning.

Authors:  V J ROUNDS
Journal:  Pediatrics       Date:  1954-11       Impact factor: 7.124

3.  Pharmacokinetic aspects of theophylline in premature newborns.

Authors:  J V Aranda; D S Sitar; W D Parsons; P M Loughnan; A H Neims
Journal:  N Engl J Med       Date:  1976-08-19       Impact factor: 91.245

4.  Physiologic changes induced by theophylline in the treatment of apnea in preterm infants.

Authors:  M J Davi; K Sankaran; K J Simons; F E Simons; M M Seshia; H Rigatto
Journal:  J Pediatr       Date:  1978-01       Impact factor: 4.406

5.  Apnoeic attacks in the newborn treated with aminophylline.

Authors:  J A Kuzemko; J Paala
Journal:  Arch Dis Child       Date:  1973-05       Impact factor: 3.791

6.  Prevention of apnea and bradycardia in low-birthweight infants.

Authors:  D C Shannon; F Gotay; I M Stein; M C Rogers; I D Todres; F M Moylan
Journal:  Pediatrics       Date:  1975-05       Impact factor: 7.124

7.  Treatment of apnea of prematurity with aminophylline.

Authors:  F J Bednarek; D W Roloff
Journal:  Pediatrics       Date:  1976-09       Impact factor: 7.124

8.  Dosage schedule for intravenous aminophylline in apnoea of prematurity, based on pharmacokinetic studies.

Authors:  R A Jones; E Baillie
Journal:  Arch Dis Child       Date:  1979-03       Impact factor: 3.791

  8 in total
  2 in total

Review 1.  Pharmacokinetics of rectal drug administration, Part II. Clinical applications of peripherally acting drugs, and conclusions.

Authors:  E J van Hoogdalem; A G de Boer; D D Breimer
Journal:  Clin Pharmacokinet       Date:  1991-08       Impact factor: 6.447

2.  Effect of aminophylline on cerebral haemodynamics and oxidative metabolism in premature infants.

Authors:  H U Bucher; M Wolf; M Keel; K von Siebenthal; G Duc
Journal:  Eur J Pediatr       Date:  1994-02       Impact factor: 3.183

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.